A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects
Clinical trial NCT04772274 · COMPLETED
Trial details
- NCT number
- NCT04772274
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2022-04-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.